Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation. (2021)
Attributed to:
Validating the PredicTR treatment response classifier for oropharyngeal cancer (PredicTR 2)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.addr.2021.113854
PubMed Identifier: 34192550
Publication URI: http://europepmc.org/abstract/MED/34192550
Type: Journal Article/Review
Volume: 176
Parent Publication: Advanced drug delivery reviews
ISSN: 0169-409X